Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components-Reference-Cited by-同舟云学术

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components

Published:2022-05-20 Issue:6 Volume:19 Page:1669-1686
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Kazemian Pardis¹²^ORCID,Yu Si-Yue³,Thomson Sarah B.¹²^ORCID,Birkenshaw Alexandra³,Leavitt Blair R.¹²,Ross Colin J. D.³

Affiliation:

1. Department of Medical Genetics, Faculty of Medicine, University of British Columbia, 317−2194 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada

2. Centre for Molecular Medicine and Therapeutics, BC Children’s Hospital Research Institute, 938 West 28th Avenue, Vancouver, British Columbia V5Z 4H4, Canada

3. Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada

Funder

Canadian Institutes of Health Research

Huntington Society of Canada

Michael Smith Foundation for Health Research

Nanomedicine Innovation Network

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.1c00916